Hempalta Statistics
Total Valuation
Hempalta has a market cap or net worth of CAD 1.68 million. The enterprise value is 1.91 million.
| Market Cap | 1.68M |
| Enterprise Value | 1.91M |
Important Dates
The last earnings date was Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Hempalta has 111.98 million shares outstanding. The number of shares has increased by 17.09% in one year.
| Current Share Class | 111.98M |
| Shares Outstanding | 111.98M |
| Shares Change (YoY) | +17.09% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.38% |
| Owned by Institutions (%) | 15.04% |
| Float | 90.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 230.57 |
| PB Ratio | -1.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.43 |
| EV / Sales | 262.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.49 |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.36 |
| Interest Coverage | -21.67 |
Financial Efficiency
Return on equity (ROE) is -155.85% and return on invested capital (ROIC) is -35.49%.
| Return on Equity (ROE) | -155.85% |
| Return on Assets (ROA) | -25.75% |
| Return on Invested Capital (ROIC) | -35.49% |
| Return on Capital Employed (ROCE) | 75.42% |
| Weighted Average Cost of Capital (WACC) | 5.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.73% in the last 52 weeks. The beta is 0.11, so Hempalta's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -72.73% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 48.63 |
| Average Volume (20 Days) | 96,202 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hempalta had revenue of CAD 7,285 and -4.49 million in losses. Loss per share was -0.05.
| Revenue | 7,285 |
| Gross Profit | 5,587 |
| Operating Income | -957,470 |
| Pretax Income | -1.18M |
| Net Income | -4.49M |
| EBITDA | -756,230 |
| EBIT | -957,470 |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 46,962 in cash and 278,600 in debt, with a net cash position of -231,638 or -0.00 per share.
| Cash & Cash Equivalents | 46,962 |
| Total Debt | 278,600 |
| Net Cash | -231,638 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -1.27M |
| Book Value Per Share | -0.01 |
| Working Capital | -1.27M |
Cash Flow
In the last 12 months, operating cash flow was -782,877 and capital expenditures 15,744, giving a free cash flow of -767,133.
| Operating Cash Flow | -782,877 |
| Capital Expenditures | 15,744 |
| Depreciation & Amortization | 201,240 |
| Net Borrowing | 152,547 |
| Free Cash Flow | -767,133 |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | 76.69% |
| Operating Margin | -13,143.03% |
| Pretax Margin | -16,222.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Hempalta does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.09% |
| Shareholder Yield | -17.09% |
| Earnings Yield | -267.27% |
| FCF Yield | -45.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 22, 2024. It was a reverse split with a ratio of 0.5882353.
| Last Split Date | Mar 22, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.5882353 |
Scores
Hempalta has an Altman Z-Score of -392.43 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -392.43 |
| Piotroski F-Score | 2 |